Innovations & Investments in Healthcare - Amiando
Innovations & Investments in Healthcare - Amiando
Innovations & Investments in Healthcare - Amiando
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Moritz von Grothuss<br />
Moritz v. Grotthuss is CEO of Genlytics and responsible for all strategic, operative and<br />
adm<strong>in</strong>istrative issues of the company. Mr. v. Grotthuss co-founded Genlytics as CEO<br />
<strong>in</strong> the beg<strong>in</strong>n<strong>in</strong>g of 2012. The company successfully started to develop an <strong>in</strong>novative‚<br />
direct to the customer‘ health portal based on <strong>in</strong>dividual genetic data.<br />
Christoph He<strong>in</strong>emann<br />
Dr. Christoph He<strong>in</strong>emann is the Vice President for Strategy & Portfolio Management for the<br />
Global Diabetes Division <strong>in</strong> Sanofi. His professional experience covers the areas of Market<strong>in</strong>g,<br />
Market Access, Bus<strong>in</strong>ess Unit Management, Strategy and Bus<strong>in</strong>ess Development <strong>in</strong> Pharmaceuticals<br />
and adjacent Medtech areas. Over the recent years he has been manag<strong>in</strong>g bus<strong>in</strong>esses<br />
<strong>in</strong> the Diabetes and Cardiovascular field <strong>in</strong> Germany and with an <strong>in</strong>ternational scope.<br />
Hartwig Jaeger<br />
Dr. Hartwig Jaeger is an MD by tra<strong>in</strong><strong>in</strong>g and has worked <strong>in</strong>tensively <strong>in</strong> the healthcare<br />
area. Follow<strong>in</strong>g his basic medical tra<strong>in</strong><strong>in</strong>g at Addenbrooke‘s hospital <strong>in</strong>d Cambridge, UK,<br />
he spent six years with McK<strong>in</strong>sey as a consultant. In the last six years he has worked for<br />
both public and private hospital groups <strong>in</strong> strategic and manag<strong>in</strong>g positions where he has<br />
focussed on restructur<strong>in</strong>g, growth and hospital plann<strong>in</strong>g.<br />
Robert Jarr<strong>in</strong><br />
Robert Jarr<strong>in</strong> is a Senior Director of Government Affairs for Qualcomm. He is based <strong>in</strong><br />
Wash<strong>in</strong>gton, DC and represents Qualcomm on U.S. domestic regulatory matters relat<strong>in</strong>g<br />
to wireless health and life sciences. Jarr<strong>in</strong>’s areas of responsibility <strong>in</strong>clude wireless health<br />
policy, FDA regulatory oversight of converged medical devices, healthcare legislative affairs,<br />
CMS telehealth reimbursement and the regulation of health <strong>in</strong>formation technology.<br />
Brian David Johnson<br />
The future is Brian David Johnson‘s bus<strong>in</strong>ess. As a futurist at Intel, his charter is to develop<br />
an actionable vision for comput<strong>in</strong>g <strong>in</strong> 2020. His work is called „future cast<strong>in</strong>g“—us<strong>in</strong>g<br />
ethnographic field studies, technology research, trend data, and even science fiction to<br />
provide Intel with a pragmatic vision of consumers and comput<strong>in</strong>g.<br />
www.iihc.eu